Search by Drug Name or NDC
NDC 00832-0722-90 Droxidopa 300 mg/1 Details
Droxidopa 300 mg/1
Droxidopa is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is DROXIDOPA.
MedlinePlus Drug Summary
Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.
Related Packages: 00832-0722-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Droxidopa
Product Information
| NDC | 00832-0722 |
|---|---|
| Product ID | 0832-0722_bfd15b0e-e34b-4f33-aeaf-4280c8c6c649 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Droxidopa |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Droxidopa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | DROXIDOPA |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Pharmaceutical Class | Catecholamines [CS], Increased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213661 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00832-0722-90 (00832072290)
| NDC Package Code | 0832-0722-90 |
|---|---|
| Billing NDC | 00832072290 |
| Package | 90 CAPSULE in 1 BOTTLE (0832-0722-90) |
| Marketing Start Date | 2021-02-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |